Soluble Toll-like receptor 4 is a potential serum biomarker in non-small cell lung cancer
Authors:
Open Access
- 20 May 2016
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (26) , 40106-40114
Abstract
Soluble Toll-like receptor 4 is a potential serum biomarker in non-small cell lung cancerKeywords
This publication has 33 references indexed in Scilit:
- Heat shock protein 27: a potential biomarker of peritoneal metastasis in epithelial ovarian cancer?Tumor Biology, 2013
- Expression and significance of HMGB1, TLR4 and NF-κB p65 in human epidermal tumorsBMC Cancer, 2013
- Links between Toll-like receptor 4 and breast cancerOncoImmunology, 2013
- Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancerRespiratory Medicine, 2009
- Cancer Cells Expressing Toll-like Receptors and the Tumor MicroenvironmentCancer Microenvironment, 2009
- The International Association for the Study of Lung Cancer Staging Project: Prognostic Factors and Pathologic TNM Stage in Surgically Managed Non-small Cell Lung CancerJournal of Thoracic Oncology, 2009
- The endogenous Toll–like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancerJournal of Leukocyte Biology, 2009
- Soluble forms of Toll-like receptor 4 are present in human saliva and modulate tumour necrosis factor-α secretion by macrophage-like cellsClinical and Experimental Immunology, 2009
- High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarminJournal of Leukocyte Biology, 2006
- Toll-Like Receptors on Tumor Cells Facilitate Evasion of Immune SurveillanceCancer Research, 2005